213 related articles for article (PubMed ID: 27292136)
1. Development and validation of a questionnaire to evaluate the Quality of Life of cats with skin disease and their owners, and its use in 185 cats with skin disease.
Noli C; Borio S; Varina A; Schievano C
Vet Dermatol; 2016 Aug; 27(4):247-e58. PubMed ID: 27292136
[TBL] [Abstract][Full Text] [Related]
2. Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats.
Noli C; Cena T
Vet Dermatol; 2015 Dec; 26(6):481-3, e112-3. PubMed ID: 26345275
[TBL] [Abstract][Full Text] [Related]
3. Interobserver reliability of Feline Dermatitis Extent and Severity Index (FEDESI) and Scoring Feline Allergic Dermatitis (SCORFAD) and the relationship between lesion scores and pruritus.
Brame BE; Canning P; Morris DO; Drobatz KJ; Rook K; Cain CL
Vet Dermatol; 2021 Oct; 32(5):492-e135. PubMed ID: 34338388
[TBL] [Abstract][Full Text] [Related]
4. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis.
Noli C; Matricoti I; Schievano C
Vet Dermatol; 2019 Apr; 30(2):110-e30. PubMed ID: 30656750
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the correlation between Scoring Feline Allergic Dermatitis and Feline Extent and Severity Index and skin hydration in atopic cats.
Szczepanik MP; Wilkołek PM; Adamek ŁR; Zając M; Gołyński M; Sitkowski W; Taszkun I
Vet Dermatol; 2018 Feb; 29(1):34-e16. PubMed ID: 28901591
[TBL] [Abstract][Full Text] [Related]
6. Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis.
Szczepanik MP; Wilkołek PM; Adamek ŁR; Kalisz G; Gołyński M; Sitkowski W; Taszkun I
Can J Vet Res; 2018 Oct; 82(4):306-311. PubMed ID: 30363310
[TBL] [Abstract][Full Text] [Related]
7. Quality of life of dogs with skin diseases and their owners. Part 1: development and validation of a questionnaire.
Noli C; Minafò G; Galzerano M
Vet Dermatol; 2011 Aug; 22(4):335-43. PubMed ID: 21410569
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness and validity of the SCORFAD, an extent and severity scale for feline hypersensitivity dermatitis.
Steffan J; Olivry T; Forster SL; Seewald W
Vet Dermatol; 2012 Oct; 23(5):410-e77. PubMed ID: 22823903
[TBL] [Abstract][Full Text] [Related]
10. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
Ortalda C; Noli C; Colombo S; Borio S
Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
[TBL] [Abstract][Full Text] [Related]
11. Use of maropitant for the control of pruritus in non-flea, non-food-induced feline hypersensitivity dermatitis: an open-label, uncontrolled pilot study.
Maina E; Fontaine J
J Feline Med Surg; 2019 Oct; 21(10):967-972. PubMed ID: 30427273
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial.
Koch SN; Torres SMF; Diaz S; Gilbert S; Rendahl A
Vet Dermatol; 2018 Apr; 29(2):107-e43. PubMed ID: 29068099
[TBL] [Abstract][Full Text] [Related]
13. Assessing Quality of Life for Pets with Dermatologic Disease and Their Owners.
Noli C
Vet Clin North Am Small Anim Pract; 2019 Jan; 49(1):83-93. PubMed ID: 30213532
[TBL] [Abstract][Full Text] [Related]
14. Prospective open pilot study on the use of ciclosporin for feline allergic skin disease.
Noli C; Scarampella F
J Small Anim Pract; 2006 Aug; 47(8):434-8. PubMed ID: 16911110
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of dogs with skin disease and of their owners. Part 2: administration of a questionnaire in various skin diseases and correlation to efficacy of therapy.
Noli C; Colombo S; Cornegliani L; Ghibaudo G; Persico P; Vercelli A; Galzerano M
Vet Dermatol; 2011 Aug; 22(4):344-51. PubMed ID: 21435044
[TBL] [Abstract][Full Text] [Related]
16. Oral dexamethasone sodium phosphate solution significantly reduces pruritus and clinical lesions in feline hypersensitivity dermatitis: an open-label study.
McClintock D; Austel M; Gogal RM; Banovic F
Vet Dermatol; 2021 Oct; 32(5):497-e137. PubMed ID: 34351657
[TBL] [Abstract][Full Text] [Related]
17. Perceptions of quality of life and priorities of owners of cats with heart disease.
Reynolds CA; Oyama MA; Rush JE; Rozanski EA; Singletary GE; Brown DC; Cunningham SM; Fox PR; Bond B; Adin DB; Williams RM; MacDonald KA; Malakoff R; Sleeper MM; Schober KE; Petrie JP; Hogan DF
J Vet Intern Med; 2010; 24(6):1421-6. PubMed ID: 20738770
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an owner-assessed Visual Analog Scale for feline pruritus severity scoring (VAScat).
Colombo S; Sartori R; Schievano C; Borio S
Vet Dermatol; 2022 Oct; 33(5):407-413. PubMed ID: 35920060
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a quality-of-life tool for cats with diabetes mellitus.
Niessen SJ; Powney S; Guitian J; Niessen AP; Pion PD; Shaw JA; Church DB
J Vet Intern Med; 2010; 24(5):1098-105. PubMed ID: 20707839
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a 0.0584% hydrocortisone aceponate spray in presumed feline allergic dermatitis: an open label pilot study.
Schmidt V; Buckley LM; McEwan NA; Rème CA; Nuttall TJ
Vet Dermatol; 2012 Feb; 23(1):11-6, e3-4. PubMed ID: 21718369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
